Skip to content
★ Sign in to follow
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€104k

Latest filing published 03 May 2023 for Catalent, Inc., €66k.

Filing timeline

BuySale
Manja Boerman

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

Manja Boerman: trading record in brief

All filings by Manja Boerman on record concern Catalent, Inc. In total, 3 filings cover trades dated from 24 August 2022 to 1 May 2023.

On the market, this insider has only sold: 2 sales, €104k in total. Outside the open market, there are 1 share grant. So far in 2023, the count stands at no purchases and 1 sale.

The record was last updated on 3 May 2023 with an open-market sale (€66k) in Catalent, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Manja Boerman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    Pres. BioModalities DivisionExecutivesCatalent, Inc.
    72,098 USD40SEC
    1,446 shares@ US$49.8663.2% of flowCommon StockSEC:0001596783-23-000023:0
  • ▼
    Pres. BioModalities DivisionExecutivesCatalent, Inc.
    40,326 USD26SEC
    780 shares@ US$51.7036.8% of flowCommon StockSEC:0001596783-22-000189:0
  • ◆
    Pres. BioModalities DivisionExecutivesCatalent, Inc.
    0SEC
    6,676 shares0Common StockSEC:0001596783-22-000109:0

3 of 3 declarations